These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 37417238)

  • 81. Association between chronic liver disease and clinical outcomes in out-of-hospital cardiac arrest.
    Pak JE; Kim KH; Shin SD; Song KJ; Hong KJ; Ro YS; Park JH
    Resuscitation; 2021 Jan; 158():1-7. PubMed ID: 33189806
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults.
    Hirode G; Saab S; Wong RJ
    JAMA Netw Open; 2020 Apr; 3(4):e201997. PubMed ID: 32239220
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Hemorrhagic stroke.
    Montaño A; Hanley DF; Hemphill JC
    Handb Clin Neurol; 2021; 176():229-248. PubMed ID: 33272397
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Population pharmacokinetic/pharmacodynamic modelling of eltrombopag in healthy volunteers and subjects with chronic liver disease.
    Farrell C; Hayes SC; Wire M; Zhang J
    Br J Clin Pharmacol; 2014 Mar; 77(3):532-44. PubMed ID: 24117976
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Treatment for restless legs syndrome secondary to chronic liver disease: a case report.
    Oguri T; Sugiyama H; Hamano T; Tachibana N
    Intern Med; 2012; 51(8):933-4. PubMed ID: 22504254
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers.
    Ricco G; Cavallone D; Cosma C; Caviglia GP; Oliveri F; Biasiolo A; Abate ML; Plebani M; Smedile A; Bonino F; Pontisso P; Brunetto MR
    Cancer Biomark; 2018 Feb; 21(3):603-612. PubMed ID: 29278878
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Chronic liver disease among Alaska-Native people, 2003-2004.
    Fischer GE; Bialek SP; Homan CE; Livingston SE; McMahon BJ
    Am J Gastroenterol; 2009 Feb; 104(2):363-70. PubMed ID: 19174808
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Discharge Disposition After Stroke in Patients With Liver Disease.
    Parikh NS; Merkler AE; Schneider Y; Navi BB; Kamel H
    Stroke; 2017 Feb; 48(2):476-478. PubMed ID: 27965428
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Repeated Lusutrombopag Treatment for Thrombocytopenia in Patients with Chronic Liver Disease.
    Sano Y; Morimoto M; Kobayashi S; Ueno M; Fukushima T; Asama H; Kawano K; Nagashima S; Tanaka S; Ohkawa S; Maeda S
    Digestion; 2021; 102(4):654-662. PubMed ID: 32841939
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Efficacy and safety of eltrombopag in Japanese patients with chronic liver disease and thrombocytopenia: a randomized, open-label, phase II study.
    Kawaguchi T; Komori A; Seike M; Fujiyama S; Watanabe H; Tanaka M; Sakisaka S; Nakamuta M; Sasaki Y; Oketani M; Hattori T; Katsura K; Sata M
    J Gastroenterol; 2012 Dec; 47(12):1342-51. PubMed ID: 22674141
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Novel functions of platelets in the liver.
    Kurokawa T; Zheng YW; Ohkohchi N
    J Gastroenterol Hepatol; 2016 Apr; 31(4):745-51. PubMed ID: 26632220
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Coronavirus disease 2019 and the liver.
    Esteban JP; Sobotka L; Rockey DC
    Curr Opin Gastroenterol; 2022 May; 38(3):191-199. PubMed ID: 35275902
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Management of COVID-19 patients with chronic liver diseases and liver transplants.
    Hu X; Sun L; Guo Z; Wu C; Yu X; Li J
    Ann Hepatol; 2022; 27(1):100653. PubMed ID: 34929350
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Management of Thrombocytopenia and Coagulopathy in Patients with Chronic Liver Disease Undergoing Therapeutic Endoscopic Interventions.
    Luther J; Friedman LS
    Clin Liver Dis; 2022 Feb; 26(1):1-12. PubMed ID: 34802655
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Evaluating medical resource utilization and costs associated with thrombocytopenia in chronic liver disease patients.
    Poordad F; Theodore D; Sullivan J; Grotzinger K
    J Med Econ; 2012; 15(1):112-24. PubMed ID: 21995622
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Outcomes associated with Clostridium difficile infection in patients with chronic liver disease.
    Dotson KM; Aitken SL; Sofjan AK; Shah DN; Aparasu RR; Garey KW
    Epidemiol Infect; 2018 Jul; 146(9):1101-1105. PubMed ID: 29739486
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Managing diabetes and liver disease association.
    Hamed AE; Elsahar M; Elwan NM; El-Nakeep S; Naguib M; Soliman HH; Ahmed Aboubakr A; AbdelMaqsod A; Sedrak H; Assaad SN; Elwakil R; Esmat G; Salh S; Mostafa T; Mogawer S; Sadek SE; Saber MM; Ezelarab H; Mahmoud AA; Sultan S; El Kassas M; Kamal E; ElSayed NM; Moussa S
    Arab J Gastroenterol; 2018 Dec; 19(4):166-179. PubMed ID: 30420265
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [The mechanisms of disorders in the hemostatic system of patients with chronic diffuse liver diseases].
    Podymova SD; Serov NA; Serov VA; Sukhanov VA; Brodskaia IK
    Ter Arkh; 1990; 62(2):72-6. PubMed ID: 2336628
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Thrombocytopenia in liver disease.
    Giannini EG; Savarino V
    Curr Opin Hematol; 2008 Sep; 15(5):473-80. PubMed ID: 18695370
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Non-viral liver disease burden in HIV-monoinfected individuals: a longitudinal observational retrospective cohort study.
    Shur NF; Tan Y; Goubet S; Fisher M; Gilleece Y; Verma S
    AIDS Care; 2016 Dec; 28(12):1522-1527. PubMed ID: 27263666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.